CPT Pharmacometrics Syst Pharmacol
Antineoplastic AgentsCarcinoma, Non-Small-Cell LungDrug Development
Dr. Adam M. Petrich, MD
NPI1407899198
- Medicare services, 2016
- 71
- Publications
- 33
- Clinical trials
- 3
- Industry payments
- $375
- State licenses
- 2
- Practice address
- 676 N. St Clair, Suite 2100, Chicago, IL 60611
- Practice phone
- Call (312) 695-6180
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Petrich's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Adam M. Petrich is a hematologist and oncologist in Chicago, Illinois
Dr. Petrich practices in Chicago, Illinois.
Dr. Petrich's NPI, 1407899198, was assigned on June 13, 2006. Dr. Petrich holds Illinois license 036.128178.
NPI and contact details
- NPI
- 1407899198NPI Registry (opens in a new tab)
- NPI enumeration date
- June 13, 2006
- NPI status
- Active
- Practice phone
- (312) 695-6180
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Adam M. Petrich's practice address is in Chicago, Illinois
Dr. Petrich's practice address in the NPI Registry is 676 N. St Clair, Suite 2100, Chicago, IL 60611. The practice phone is (312) 695-6180.
- NPI Registry address676 N. St Clair, Suite 2100, Chicago, IL 60611Phone(312) 695-6180
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Adam M. Petrich's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Petrich practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Petrich's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Petrich practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Adam M. Petrich is one of 563 hematologists and oncologists in Illinois
Hematology and oncology is Dr. Petrich's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Petrich's licenses on file in 2 states: Illinois and Wisconsin.
Specialties and state licenses
- Hematology and oncology, IllinoisPrimary
- Internal medicine, Wisconsin
Hematologists and oncologists near Dr. Petrich
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Adam M. Petrich billed Medicare for 71 services in 2016
CMS data shows 71 Medicare services from Dr. Petrich across 3 procedure codes in 2016. Medicare paid $448 for them. Every service was in an office.
Medicare services, 201671
Paid by Medicare$448
Procedure codes3
Dr. Petrich's Medicare services by type, 2016
- Lab and pathology47
- Surgery24
Dr. Petrich compared with the Illinois median for hematologists and oncologists, 2016
- Dr. Petrich
- Illinois median
- Medicare services
- 71vs 1,05693% below
Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.
Dr. Petrich's most billed Medicare procedure codes, 2016
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Petrich?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Petrich and other hematologists and oncologists in Illinois.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Petrich by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Adam M. Petrich has 33 publications on record
Dmand AI links 33 papers to Dr. Petrich, published from 2010 to 2023. 2014 was the busiest year, with 7. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Remission Induction and Rituximab. Dr. Petrich has published most often in Blood Adv. Dr. Petrich's most frequent co-authors are Leo I. Gordon, MD, Chadi Nabhan, MBA, MD and Reem Md Karmali, MD.
Papers33
Years published2010 to 2023
Dr. Petrich's papers by year, 2010 to 2023
Topics Dr. Petrich writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Remission Induction
- Rituximab
- Transplantation, Autologous
- Antineoplastic Agents
- Hematopoietic Stem Cell Transplantation
- Hodgkin Disease
- Lenalidomide
Dr. Petrich's most frequent co-authors
- Leo I. Gordon, MD9 shared papers
- Chadi Nabhan, MBA, MD8 shared papers
- Reem Md Karmali, MD7 shared papers
Recent publications by Dr. Petrich
Antineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationHodgkin Disease
See who Dr. Petrich researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Petrich works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Adam M. Petrich has worked on 3 clinical trials
Dmand AI links Dr. Petrich to 3 clinical trials, 2 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Large Granular Lymphocytic, Lymphoma, Extranodal NK-T-Cell and Plasmablastic Lymphoma. Northwestern University sponsors the most, 3.
Clinical trials with Dr. Petrich by phase
- NonePhase 1: no trials
- 2Phase 1/2: 2 trials
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Petrich's trials
- Leukemia, Large Granular Lymphocytic
- Lymphoma, Extranodal NK-T-Cell
- Plasmablastic Lymphoma
- Burkitt Lymphoma
- Intraocular Lymphoma
Investigators on the most trials with Dr. Petrich
- Andrew M. Evens, DO, MS2 shared trials
- Steven T. Rosen, MD2 shared trials
- Leo I. Gordon, MD1 shared trial
Recent clinical trials with Dr. Petrich
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma (opens in a new tab)
Status unknownPhase 1/2
Plasmablastic LymphomaBurkitt LymphomaIxazomib CitrateRituximabCyclophosphamide
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma (opens in a new tab)
Active, not recruitingPhase 2
Lymphoma, Extranodal NK-T-CellLymphoma, T-Cell, PeripheralLenalidomideRomidepsin
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas (opens in a new tab)
TerminatedPhase 1/2
Leukemia, Large Granular LymphocyticIntraocular LymphomaBrentuximab vedotinRituximab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Adam M. Petrich received $375 in industry payments from 2016 to 2023
CMS Open Payments shows 8 general payments to Dr. Petrich from 5 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Aurobindo Pharma USA, Inc. paid the most, $171. It also lists 1 research payment totaling $2,163 in 2020.
General payments to Dr. Petrich by program year, 2016 to 2023
Companies that paid Dr. Petrich the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Adam M. Petrich's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Adam M. Petrich
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Adam M. Petrich's NPI number?
Dr. Adam M. Petrich's NPI number is 1407899198. It was assigned on June 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Adam M. Petrich?
Dr. Adam M. Petrich is a hematologist and oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Adam M. Petrich practice?
Dr. Petrich practices at 676 N. St Clair, Suite 2100, Chicago, IL 60611.
What is Dr. Adam M. Petrich's office phone number?
The practice phone on file for Dr. Petrich is (312) 695-6180.
What is Dr. Adam M. Petrich's medical license number?
Dr. Petrich holds Illinois license 036.128178, one of the licenses on file in 2 states.
Which states has Dr. Adam M. Petrich been licensed in?
Dmand AI has state licenses on file for Dr. Petrich in Illinois and Wisconsin.
Does Dr. Adam M. Petrich accept Medicare?
Yes. CMS data shows Dr. Petrich billed Medicare for 71 services in 2016.
What services does Dr. Adam M. Petrich bill to Medicare?
In 2016, Dr. Petrich's most billed Medicare services were surgery: heart and blood vessels (36415), lab and pathology test (85025) and lab and pathology test (83615).
Has Dr. Adam M. Petrich received payments from drug or device companies?
CMS Open Payments shows $375 in general payments to Dr. Petrich from 5 companies from 2016 to 2023. The largest total came from Aurobindo Pharma USA, Inc.
How long has Dr. Adam M. Petrich been practicing?
Dr. Petrich's NPI was assigned in 2006.
Does Dr. Adam M. Petrich do research?
Dmand AI links 33 publications to Dr. Petrich, published from 2010 to 2023. Dr. Petrich has worked on 3 clinical trials.
Who does Dr. Adam M. Petrich publish with?
Dr. Petrich's most frequent co-authors are Leo I. Gordon, MD (9 shared papers), Chadi Nabhan, MBA, MD (8 shared papers) and Reem Md Karmali, MD (7 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card